Pharmacists in Farmington, New Mexico


44 Pharmacists found in Farmington
female pharmacist

Mary Hayashi, RPH


Pharmacist
4500 E Main St, Farmington, NM 87402
505-326-5384     505-326-6920

female pharmacist

Meagan La Chance, PHARM D


Pharmacist
600 E 20th St, Farmington, NM 87401
505-325-1774    

male pharmacist

Dr. Michael Chantz Eyring, PHARMD


Pharmacist
701 E 20th St, Farmington, NM 87401
505-326-3342     505-325-4694



male pharmacist

Michael Kekoa Andrews, PHARMD


Pharmacist
600 E 20th St, Farmington, NM 87401
505-325-1774    

female pharmacist

Natalia Carmen Mendez, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
409 Kathleen Pl, Farmington, NM 87401
505-917-5943    

male pharmacist

Mr. Pablo Viramontes Iv, RPH


Pharmacist
4900 E Main St, T-0952, Farmington, NM 87402
505-327-3555    

male pharmacist

Percy E Collyer, PHARMD


Pharmacist
4221 E Main St, Farmington, NM 87402
505-325-1749     505-325-0262

female pharmacist

Dr. Rebecca Karen Schonemann, PHARM.D.


Pharmacist
1309 Griffin Ave Apt 6, Farmington, NM 87401
505-675-5821    

male pharmacist

Robert Bradford Snapp, RPH


Pharmacist
4604 Samantha Ln, Farmington, NM 87402
505-486-0379    

female pharmacist

Stacey Mclendon, PHARMD


Pharmacist
801 W Maple St, Farmington, NM 87401
505-486-5264    

female pharmacist

Stephanie Elizabeth Allen, PHARMD


Pharmacist - Pharmacotherapy
816 Sunrise Ct, Farmington, NM 87401
563-579-8577    

male pharmacist

Dr. Yancey Natividad


Pharmacist
600 E 20th St, Farmington, NM 87401
505-325-1774    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.